单核苷酸多态性分析暗示mTOR信号在移植后新发糖尿病的发展

S. Chand , A.J. McKnight , S. Shabir , W. Chan , J.A. McCaughan , A.P. Maxwell , L. Harper , R. Borrows
{"title":"单核苷酸多态性分析暗示mTOR信号在移植后新发糖尿病的发展","authors":"S. Chand ,&nbsp;A.J. McKnight ,&nbsp;S. Shabir ,&nbsp;W. Chan ,&nbsp;J.A. McCaughan ,&nbsp;A.P. Maxwell ,&nbsp;L. Harper ,&nbsp;R. Borrows","doi":"10.1016/j.bbacli.2015.12.004","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p>Despite excellent first year outcomes in kidney transplantation, there remain significant long-term complications related to new-onset diabetes after transplantation (NODAT). The purpose of this study was to validate the findings of previous investigations of candidate gene variants in patients undergoing a protocolised, contemporary immunosuppression regimen, using detailed serial biochemical testing to identify NODAT development.</p></div><div><h3>Methods</h3><p>One hundred twelve live and deceased donor renal transplant recipients were prospectively followed-up for NODAT onset, biochemical testing at days 7, 90, and 365 after transplantation. Sixty-eight patients were included after exclusion for non-white ethnicity and pre-transplant diabetes. Literature review to identify candidate gene variants was undertaken as described previously.</p></div><div><h3>Results</h3><p>Over 25% of patients developed NODAT. In an adjusted model for age, sex, BMI, and BMI change over 12<!--> <!-->months, five out of the studied 37 single nucleotide polymorphisms (SNPs) were significantly associated with NODAT: rs16936667:PRDM14 OR 10.57;95% CI 1.8–63.0;p<!--> <!-->=<!--> <!-->0.01, rs1801282:PPARG OR 8.5; 95% CI 1.4–52.7; p<!--> <!-->=<!--> <!-->0.02, rs8192678:PPARGC1A OR 0.26; 95% CI 0.08–0.91; p<!--> <!-->=<!--> <!-->0.03, rs2144908:HNF4A OR 7.0; 95% CI 1.1–45.0;p<!--> <!-->=<!--> <!-->0.04 and rs2340721:ATF6 OR 0.21; 95%CI 0.04–1.0; p<!--> <!-->=<!--> <!-->0.05.</p></div><div><h3>Conclusion</h3><p>This study represents a replication study of candidate SNPs associated with developing NODAT and implicates mTOR as the central regulator via altered insulin sensitivity, pancreatic β cell, and mitochondrial survival and dysfunction as evidenced by the five SNPs.</p></div><div><h3>General significance</h3><p></p><ul><li><span>1)</span><span><p>Highlights the importance of careful biochemical phenotyping with oral glucose tolerance tests to diagnose NODAT in reducing time to diagnosis and missed cases.</p></span></li><li><span>2)</span><span><p>This alters potential genotype:phenotype association.</p></span></li><li><span>3)</span><span><p>The replication study generates the hypothesis that mTOR signalling pathway may be involved in NODAT development.</p></span></li></ul></div>","PeriodicalId":72344,"journal":{"name":"BBA clinical","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2016-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.bbacli.2015.12.004","citationCount":"13","resultStr":"{\"title\":\"Analysis of single nucleotide polymorphisms implicate mTOR signalling in the development of new-onset diabetes after transplantation\",\"authors\":\"S. Chand ,&nbsp;A.J. McKnight ,&nbsp;S. Shabir ,&nbsp;W. Chan ,&nbsp;J.A. McCaughan ,&nbsp;A.P. Maxwell ,&nbsp;L. Harper ,&nbsp;R. Borrows\",\"doi\":\"10.1016/j.bbacli.2015.12.004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><p>Despite excellent first year outcomes in kidney transplantation, there remain significant long-term complications related to new-onset diabetes after transplantation (NODAT). The purpose of this study was to validate the findings of previous investigations of candidate gene variants in patients undergoing a protocolised, contemporary immunosuppression regimen, using detailed serial biochemical testing to identify NODAT development.</p></div><div><h3>Methods</h3><p>One hundred twelve live and deceased donor renal transplant recipients were prospectively followed-up for NODAT onset, biochemical testing at days 7, 90, and 365 after transplantation. Sixty-eight patients were included after exclusion for non-white ethnicity and pre-transplant diabetes. Literature review to identify candidate gene variants was undertaken as described previously.</p></div><div><h3>Results</h3><p>Over 25% of patients developed NODAT. In an adjusted model for age, sex, BMI, and BMI change over 12<!--> <!-->months, five out of the studied 37 single nucleotide polymorphisms (SNPs) were significantly associated with NODAT: rs16936667:PRDM14 OR 10.57;95% CI 1.8–63.0;p<!--> <!-->=<!--> <!-->0.01, rs1801282:PPARG OR 8.5; 95% CI 1.4–52.7; p<!--> <!-->=<!--> <!-->0.02, rs8192678:PPARGC1A OR 0.26; 95% CI 0.08–0.91; p<!--> <!-->=<!--> <!-->0.03, rs2144908:HNF4A OR 7.0; 95% CI 1.1–45.0;p<!--> <!-->=<!--> <!-->0.04 and rs2340721:ATF6 OR 0.21; 95%CI 0.04–1.0; p<!--> <!-->=<!--> <!-->0.05.</p></div><div><h3>Conclusion</h3><p>This study represents a replication study of candidate SNPs associated with developing NODAT and implicates mTOR as the central regulator via altered insulin sensitivity, pancreatic β cell, and mitochondrial survival and dysfunction as evidenced by the five SNPs.</p></div><div><h3>General significance</h3><p></p><ul><li><span>1)</span><span><p>Highlights the importance of careful biochemical phenotyping with oral glucose tolerance tests to diagnose NODAT in reducing time to diagnosis and missed cases.</p></span></li><li><span>2)</span><span><p>This alters potential genotype:phenotype association.</p></span></li><li><span>3)</span><span><p>The replication study generates the hypothesis that mTOR signalling pathway may be involved in NODAT development.</p></span></li></ul></div>\",\"PeriodicalId\":72344,\"journal\":{\"name\":\"BBA clinical\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.bbacli.2015.12.004\",\"citationCount\":\"13\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"BBA clinical\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2214647416000040\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"BBA clinical","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2214647416000040","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 13

摘要

尽管肾移植第一年的预后很好,但移植后新发糖尿病(NODAT)仍然存在显著的长期并发症。本研究的目的是验证先前在接受规范的当代免疫抑制方案的患者中对候选基因变异的调查结果,使用详细的系列生化测试来识别NODAT的发展。方法对112例活体和死亡供肾移植受者在移植后第7天、第90天和第365天进行NODAT发病和生化检测。排除非白种人和移植前糖尿病后纳入68例患者。如前所述,进行文献综述以确定候选基因变异。结果超过25%的患者发生NODAT。在年龄、性别、BMI和BMI在12个月内变化的调整模型中,研究的37个单核苷酸多态性(snp)中有5个与NODAT显著相关:rs16936667:PRDM14 OR 10.57, 95% CI 1.8-63.0, p = 0.01, rs1801282:PPARG OR 8.5;95% ci 1.4-52.7;p = 0.02, rs8192678:PPARGC1A OR 0.26;95% ci 0.08-0.91;p = 0.03, rs2144908:HNF4A OR 7.0;95% CI 1.1-45.0;p = 0.04, rs2340721:ATF6 OR 0.21;95%可信区间0.04 - -1.0;p = 0.05。本研究是一项与NODAT发生相关的候选snp的复制研究,并暗示mTOR通过改变胰岛素敏感性、胰腺β细胞、线粒体存活和功能障碍作为中心调节因子,这五个snp证明了这一点。一般意义1)强调了通过口服糖耐量试验进行细致的生化表型分析对诊断NODAT的重要性,减少了诊断时间和漏诊病例2)这改变了潜在的基因型:表型相关性3)重复性研究提出了mTOR信号通路可能参与NODAT发展的假设。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Analysis of single nucleotide polymorphisms implicate mTOR signalling in the development of new-onset diabetes after transplantation

Introduction

Despite excellent first year outcomes in kidney transplantation, there remain significant long-term complications related to new-onset diabetes after transplantation (NODAT). The purpose of this study was to validate the findings of previous investigations of candidate gene variants in patients undergoing a protocolised, contemporary immunosuppression regimen, using detailed serial biochemical testing to identify NODAT development.

Methods

One hundred twelve live and deceased donor renal transplant recipients were prospectively followed-up for NODAT onset, biochemical testing at days 7, 90, and 365 after transplantation. Sixty-eight patients were included after exclusion for non-white ethnicity and pre-transplant diabetes. Literature review to identify candidate gene variants was undertaken as described previously.

Results

Over 25% of patients developed NODAT. In an adjusted model for age, sex, BMI, and BMI change over 12 months, five out of the studied 37 single nucleotide polymorphisms (SNPs) were significantly associated with NODAT: rs16936667:PRDM14 OR 10.57;95% CI 1.8–63.0;p = 0.01, rs1801282:PPARG OR 8.5; 95% CI 1.4–52.7; p = 0.02, rs8192678:PPARGC1A OR 0.26; 95% CI 0.08–0.91; p = 0.03, rs2144908:HNF4A OR 7.0; 95% CI 1.1–45.0;p = 0.04 and rs2340721:ATF6 OR 0.21; 95%CI 0.04–1.0; p = 0.05.

Conclusion

This study represents a replication study of candidate SNPs associated with developing NODAT and implicates mTOR as the central regulator via altered insulin sensitivity, pancreatic β cell, and mitochondrial survival and dysfunction as evidenced by the five SNPs.

General significance

  • 1)

    Highlights the importance of careful biochemical phenotyping with oral glucose tolerance tests to diagnose NODAT in reducing time to diagnosis and missed cases.

  • 2)

    This alters potential genotype:phenotype association.

  • 3)

    The replication study generates the hypothesis that mTOR signalling pathway may be involved in NODAT development.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Body mass index is associated with region-dependent metabolic reprogramming of adipose tissue Rapid diagnosis and intraoperative margin assessment of human lung cancer with fluorescence lifetime imaging microscopy Accumulated substancies and calorific capacity in adipose tissue: Physical and chemical clinical trial Abnormal amyloid β42 expression and increased oxidative stress in plasma of CKD patients with cognitive dysfunction: A small scale case control study comparison with Alzheimer's disease Novel panel of protein biomarkers to predict response to bortezomib-containing induction regimens in multiple myeloma patients
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1